This article is part of a Chronicle. See more from this Chronicle
Ankur Kapoor, Rosa Morales, Oct 29, 2014
As the first reverse-payment antitrust case to go to a jury since the watershed U.S. Supreme Court case, FTC v. Actavis—indeed, the first such case to be tried, ever— In re Nexium (Esomeprazole) Antitrust Litigation promises to help map the U.S. legal landscape left largely unexplored by the Supreme Court in Actavis concerning the antitrust analysis of reverse-payment settlements. A
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 3.15.3.154
Please verify email or join us to access premium content!